Loading interface...

Clarigard 125 mg/5 ml Suspension

Manufactured byMacleods Pharmaceuticals Pvt. Ltd.
Description

Clarigard 125 mg/5 ml Suspension is a macrolide antibiotic used in the treatment of bacterial infections affecting airways, lungs, throat, ears, skin, etc. It is also used with other medications for the treatment of helicobacter pylori infections that cause peptic ulcer disease.

Side effects

Major & minor side effects for Clarigard 125 mg/5 ml Suspension

  • Indigestion
  • Stomach pain
  • Nausea and Vomiting
  • Diarrhea
  • Itching and skin rash
  • Acid or sour stomach
  • Excessive gas in stomach
  • Headache
  • Heartburn
  • Dizziness
  • Lower back pain
  • Change in taste/ Metallic taste

Uses of Clarigard 125 mg/5 ml Suspension

What is it prescribed for?

  • Pharyngitis/Tonsilitis
  • Acute exacerbation of chronic bronchitis
  • Community acquired pneumonia
  • Acute maxillary Sinusitis
  • Bacterial Ear Infections
  • Peptic Ulcer
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The onset of action for Clarigard 125 mg/5 ml Suspension is not clinically determined.
  • How long do the effects of this medicine last?
    The duration of action for Clarigard 125 mg/5 ml Suspension is not clinically determined.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit-forming tendency has been reported for Clarigard 125 mg/5 ml Suspension.
  • Can this medicine be taken during pregnancy?
    Use Clarigard 125 mg/5 ml Suspension for pregnant women only under the supervision of the physician.
  • Can this medicine be taken while breast-feeding?
    Use Clarigard 125 mg/5 ml Suspension for lactating/breastfeeding women only under the supervision of the physician.

Allergy

Avoid taking Clarigard 125 mg/5 ml Suspension if you are allergic to it, other macrolides, or any other components present in the formulation.

Liver damage

Clarigard 125 mg/5 ml Suspension is contraindicated in patients with a history of cholestatic jaundice (a condition of reduced bile flow from the liver to the small intestine) or impaired liver function associated with prior use of this medicine.

Statins

The combined use of Clarigard 125 mg/5 ml Suspension and statins such as atorvastatin, simvastatin, etc., cause serious side effects on muscles such as pain, tenderness, or weakness.
Warnings for special population

Pregnancy

Use Clarigard 125 mg/5 ml Suspension for pregnant women only under the supervision of the physician.

Breast-feeding

Use Clarigard 125 mg/5 ml Suspension for lactating/breastfeeding women only under the supervision of the physician.
General warnings

Myasthenia gravis

Clarigard 125 mg/5 ml Suspension should be used with extreme caution in patients with a skeletal muscle weakness condition called myasthenia gravis as it may worsen the condition.

Antacids

Clarigard 125 mg/5 ml Suspension when used along with antacids containing aluminum and magnesium salts may decrease the desired effects of the medicine. Hence it should be taken at least 1 hour before or 2 hours after taking antacids.

Antibiotic resistance

Finish the entire course of treatment with Clarigard 125 mg/5 ml Suspension, even if the condition gets better to avoid antibiotic resistance.

Diarrhea

Therapy with Clarigard 125 mg/5 ml Suspension may cause diarrhea. Seek medical attention if you experience persistent diarrhea.

Driving or operating machinery

Therapy with Clarigard 125 mg/5 ml Suspension may cause dizziness, confusion, disorientation, etc. in some patients. Hence it is advised not to perform any activities such as driving a vehicle or operating machinery if you experience any of these symptoms.

Missed Dose

Try not to skip a dose. And if a dose is skipped, do not add it up to the next dose.

Overdose

Seek emergency medical attention in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Clonazepam

Pimozide

Carbamazepine

Amiodarone

Ethinyl Estradiol

Atorvastatin

Disease interactions

QT Prolongation

An electrical heartbeat disturbance called prolonged QT intervals have been observed in some patients receiving Clarigard 125 mg/5 ml Suspension especially those who are taking heart medications.

Gastrointestinal Disorders

Use Clarigard 125 mg/5 ml Suspension with extreme caution in patients with gastrointestinal (mouth to anus) diseases, particularly colitis (swelling of the inner lining of the colon), since it may worsen the patient's condition.

Kidney Disease

Clarigard 125 mg/5 ml Suspension should be used with caution in patients with kidney diseases due to the risk of worsening of the condition. Dose adjustment or a suitable alternative might be required in such patients based on the clinical condition.
Food interactions
Information not available.
Lab interactions
Information not available.
Take the medicine as instructed by the doctor. Do not take in larger amounts than advised. Take the medicine at around the same time daily.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

May cause sleepiness

How it works
Clarigard 125 mg/5 ml Suspension works by inhibiting the growth of bacteria within the body.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Macrolides

Schedule

Schedule H

Medicines.org.uk. 2020. [online] Available at: < [Accessed 26 December 2020].

https://www.medicines.org.uk/emc/files/pil.7072.pdf>

Drugs, H., 2020. Clarithromycin: Medlineplus Drug Information. [online] Medlineplus.gov. Available at: < [Accessed 22 December 2020].

https://medlineplus.gov/druginfo/meds/a692005.html>

Mri.cts-mrp.eu. 2020. [online] Available at: < [Accessed 26 December 2020].

https://mri.cts-mrp.eu/human/downloads/BE_H_0166_002_FinalPL.pdf>

Clarithromycin | Drugbank Online. [online] Available at: < [Accessed 30 December 2020]

https://go.drugbank.com/drugs/DB01211>

Pubchem.ncbi.nlm.nih.gov. 2020. Clarithromycin. [online] Available at: < [Accessed 30 December 2020].

https://pubchem.ncbi.nlm.nih.gov/compound/Clarithromycin>

Go.drugbank.com. 2020. Clarithromycin | Drugbank Online. [online] Available at: < [Accessed 30 December 2020].

https://go.drugbank.com/drugs/DB01211>
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 31 Dec 2020

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.